CIK: 1189001 - Address: , ,
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1111-7017-8225
P%wins1000100100010067
S%ret1110112312206
S%wins30403050201030

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/27/20 18:57
1/8/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.dm39150.9808999%8D
1/27/20 18:57
1/8/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.dm-50365.660-8-498D
7/29/19 18:06
7/26/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d25531.910814913D
7/29/19 18:06
7/26/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.d-55869.770-8-3713D
8/1/18 18:11
7/30/18
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d48622.1002213D
8/1/18 18:11
7/30/18
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.d-1,76980.410-22-6213D
7/23/18 21:19
7/20/18
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS-44082.560-5-408D
3/27/18 07:58
3/23/18
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d6110.17068113D
3/27/18 07:58
3/23/18
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.d-37562.470-6-3113D
8/2/17 08:13
8/1/17
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d5011.06058110D
9/24/15 18:00
9/22/15
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDP19147.801043545D2120-10-16-7-10-111-7017-822
7/24/15 16:41
7/22/15
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS-24861.9912-4-781D51362126232620212-1-8-16-9-3
10/3/11 17:15
9/30/11
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS-3534.6010-1-214D626-16-2358465419-42232
9/30/11 13:11
9/29/11
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS-3434.1110-1-273D612-16-23172-30-114-111323
10/12/10 16:50
10/7/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.dm11311.025102D1087036272162335414172
10/12/10 16:50
10/7/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.dm-35034.015-10-862D1087036272162335414172
10/7/10 18:20
10/5/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.dm188.35522D836035281690315819261
10/7/10 18:20
10/5/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.dm-7234.065-2-562D836035281690315819261
10/4/10 21:43
10/1/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d269.09532D725329271531-633124255
10/4/10 21:43
10/1/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.d-9332.975-3-632D725329271531-633124255
10/1/10 18:37
9/29/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.dm247.70632D805735312294013227266
10/1/10 18:37
9/29/10
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.dm-10834.296-3-652D805735312294013227266
10/22/08 15:43
10/21/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDM.d777.696101D13125242320102616-6-13-28-26-292
10/22/08 15:43
10/21/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS.d-30730.706-10-901D13125242320102616-6-13-28-26-292
9/28/06 16:29
9/27/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDS-18421.381-9-921D1630-812148972-1-201066
8/29/06 09:51
8/23/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticReed Thomas HDOBoard ofS-2719.501-1-139D216-16-46-12-1-121261961

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact